How To Use CPT Code 90283

CPT 90283 describes the administration of intravenous immunoglobulin (IgIV), a complex protein that provides passive immunity and protects the body against various infections. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90283?

CPT 90283 involves the slow administration of intravenous immunoglobulin (IgIV), which is a complex protein that helps the body defend against different types of infections and provides passive immunity. This code is used to report the administration of IgIV through an appropriately sized needle.

2. Official Description

The official description of CPT code 90283 is: ‘Immune globulin (IgIV), human, for intravenous use.’

3. Procedure

  1. The healthcare professional inspects the site where the intravenous immunoglobulin injection will be administered.
  2. Using an appropriately sized needle, the healthcare professional slowly administers the intravenous immunoglobulin.

4. Qualifying circumstances

CPT 90283 is used when a healthcare professional administers intravenous immunoglobulin (IgIV) to a patient. This procedure is typically performed when the patient requires passive immunity or protection against various infections. The administration should be done by a qualified healthcare professional using an appropriate needle size.

5. When to use CPT code 90283

CPT code 90283 should be used when a healthcare professional administers intravenous immunoglobulin (IgIV) to a patient. It is important to ensure that the administration is done slowly and using the correct needle size. This code should not be used for other types of immunoglobulin administration or for non-intravenous routes of administration.

6. Documentation requirements

To support a claim for CPT 90283, the healthcare professional must document the following information:

  • Patient’s need for intravenous immunoglobulin (IgIV) administration
  • Date and time of the administration
  • Details of the administration procedure, including the use of an appropriately sized needle
  • Any adverse reactions or complications
  • Signature of the healthcare professional performing the administration

7. Billing guidelines

When billing for CPT 90283, ensure that the administration is performed by a qualified healthcare professional and that the procedure is documented appropriately. It is important to report the administration code separately from other services. Take note of any specific guidelines or modifiers that may be required for accurate billing.

8. Historical information

CPT 90283 was added to the Current Procedural Terminology system on January 1, 1999. There have been no updates or changes to the code since its addition.

9. Examples

  1. A nurse slowly administers intravenous immunoglobulin (IgIV) to a patient with primary immunodeficiency.
  2. A physician administers intravenous immunoglobulin (IgIV) to a patient with autoimmune hemolytic anemia.
  3. A healthcare professional administers intravenous immunoglobulin (IgIV) to a patient with Kawasaki disease.
  4. A nurse slowly administers intravenous immunoglobulin (IgIV) to a patient with chronic inflammatory demyelinating polyneuropathy.
  5. A physician administers intravenous immunoglobulin (IgIV) to a patient with Guillain-Barré syndrome.
  6. A healthcare professional administers intravenous immunoglobulin (IgIV) to a patient with multifocal motor neuropathy.
  7. A nurse slowly administers intravenous immunoglobulin (IgIV) to a patient with immune thrombocytopenic purpura.
  8. A physician administers intravenous immunoglobulin (IgIV) to a patient with myasthenia gravis.
  9. A healthcare professional administers intravenous immunoglobulin (IgIV) to a patient with chronic lymphocytic leukemia.
  10. A nurse slowly administers intravenous immunoglobulin (IgIV) to a patient with hypogammaglobulinemia.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *